tiprankstipranks
Trending News
More News >
Argenica Therapeutics Ltd (AU:AGN)
ASX:AGN
Australian Market
Advertisement

Argenica Therapeutics Ltd (AGN) Income Statement

Compare
12 Followers

Argenica Therapeutics Ltd Income Statement

Last quarter (Q4 2025), Argenica Therapeutics Ltd's total revenue was AU$379.87K, an increase of Infinity% from the same quarter last year. In Q4, Argenica Therapeutics Ltd's net income was AU$-5.98M. See Argenica Therapeutics Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 3.21MAU$ 2.60MAU$ 0.00AU$ 259.10KAU$ 296.07K
Gross Profit
AU$ 3.21MAU$ 2.60MAU$ 1.75MAU$ 259.10KAU$ 296.07K
Operating Expenses
AU$ 10.90MAU$ 8.27MAU$ 6.62MAU$ 4.35MAU$ 1.33M
Depreciation and Amortization
AU$ 7.68MAU$ 5.67MAU$ 4.87MAU$ 4.09MAU$ 0.00
EBITDA
AU$ 0.00AU$ -1.90MAU$ -4.81MAU$ -4.09MAU$ -1.33M
Operating Income
AU$ -7.68MAU$ -5.67MAU$ -6.62MAU$ -4.09MAU$ -1.03M
Other Income/Expenses
AU$ 512.25KAU$ -1.90MAU$ 431.93KAU$ 1.68KAU$ 182.00
Pretax Income
AU$ -7.17MAU$ -7.57MAU$ -6.19MAU$ -4.09MAU$ -1.03M
Net Income
AU$ -7.17MAU$ -5.48MAU$ -4.82MAU$ -4.09MAU$ -1.03M
Per Share Metrics
Basic EPS
AU$ -0.06AU$ -0.05AU$ -0.06AU$ -0.06AU$ -0.01
Diluted EPS
AU$ -0.06AU$ -0.05AU$ -0.06AU$ -0.06AU$ -0.01
Weighted Average Shares Outstanding
127.53M 103.39M 87.58M 73.93M 73.17M
Weighted Average Shares Outstanding (Diluted)
127.53M 103.71M 87.58M 73.93M 73.17M
Currency in AUD

Argenica Therapeutics Ltd Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis